Physician

Wendell R Helveston, MD

According to 2025 Medicare claims, Wendell Helveston, MD (NPI: 1881607158) practices neurology in the Hattiesburg, MS market, with the plurality of this provider's patient population coming from Forrest, MS. This provider's primary affiliated billing organization is HATTIESBURG CLINIC PA (NPI: 1740213446; TIN: 640507572) and primary practice location at 39402-3262. Helveston is affiliated with the Hattiesburg Clinic ACO (ACO ID: A2880) and Ochsner Senior Care Network, LLC (ACO ID: A5662), participating under the MSSP model.

Helveston's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 888 traditional Medicare patients, billed 515,597 HCPCS/CPT codes, and received $2,665,005 in Medicare payments. The top billing code was 95816 (Measurement of brain wave activity (eeg), awake and drowsy). Part D data shows 6,870 prescription claims across 769 beneficiaries totaling $3,749,049 in drug costs, led by Nuplazid (Pimavanserin Tartrate). 2023 DME data shows 11 claims. Open Payments data shows 436 records totaling $176,854. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,245,116 to $2,665,005. Similarly, Part D prescription costs have risen steadily, from $1,707,154 to $3,749,049. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $5,507 to $1,558.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.1M$4.1M2015 Medicare payment: $1,245,116 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,456,544 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,145,345 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,635,553 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,107,419 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,332,012 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,507,708 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,459,943 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,149,628 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,665,005 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,17656,752$1,245,116
20161,19368,564$1,456,544
20171,18051,203$1,145,345
20181,10270,760$2,635,553
20191,15785,730$4,107,419
202092167,438$3,332,012
202191658,845$2,507,708
202288775,269$2,459,943
2023833169,803$2,149,628
2024888515,597$2,665,005

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.9M$3.7M2015 Drug cost: $1,707,154 (USD; Tot_Drug_Cst)2016 Drug cost: $1,771,182 (USD; Tot_Drug_Cst)2017 Drug cost: $2,128,743 (USD; Tot_Drug_Cst)2018 Drug cost: $1,859,111 (USD; Tot_Drug_Cst)2019 Drug cost: $2,528,241 (USD; Tot_Drug_Cst)2020 Drug cost: $2,962,410 (USD; Tot_Drug_Cst)2021 Drug cost: $3,320,886 (USD; Tot_Drug_Cst)2022 Drug cost: $2,464,415 (USD; Tot_Drug_Cst)2023 Drug cost: $2,886,402 (USD; Tot_Drug_Cst)2024 Drug cost: $3,749,049 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155935,247$1,707,154
20166215,003$1,771,182
20175844,626$2,128,743
20185964,195$1,859,111
20196394,925$2,528,241
20206796,438$2,962,410
20217076,486$3,320,886
20227235,789$2,464,415
20237396,518$2,886,402
20247696,870$3,749,049

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.4K$2.8K2015 Medicare payment: $2,769 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $251 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $271 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $347 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $316 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $257 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R26$2,769
2016N/R14$251
2017N/R20$271
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R13$347
2021N/R16$316
2022N/RN/RN/R
2023N/R11$257
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
95816Measurement of brain wave activity (eeg), awake and drowsy110119$107
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more122122$104
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more324522$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more504857$56
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's393748$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
NuplazidPimavanserin Tartrate1474,710$739,391
EpidiolexCannabidiol (Cbd)742,190$403,599
XcopriCenobamate1655,018$256,138
IngrezzaValbenazine Tosylate15690$180,302
Nurtec OdtRimegepant Sulfate1021,948$123,061

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.436$176,854Eisai Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Wendell R. Helveston, MD?

Tedicare shows public-source Medicare data for Wendell R. Helveston, MD (NPI 1881607158), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wendell R. Helveston, MD have ACO affiliation data?

Wendell R. Helveston, MD is shown with ACO affiliation data for Hattiesburg Clinic ACO (MSSP, ACO ID A2880) and Ochsner Senior Care Network, LLC (MSSP, ACO ID A5662).

What billing organization is linked to Wendell R. Helveston, MD?

Wendell R. Helveston, MD is linked to HATTIESBURG CLINIC PA (billing NPI 1740213446) in the available physician profile data.

Does Wendell R. Helveston, MD have Open Payments data?

Wendell R. Helveston, MD has 436 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.